SCHEMBL5170746

SCHEMBL5170746

CNn1c(O)cc2sccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.37
KDM1A O60341 6/20 0.37
RCOR1 Q9UKL0 6/20 0.37
RAB9A P51151 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NPC1 O15118 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
LMNA P02545 1/20 0.36
TSHR P16473 4/20 0.35
NPSR1 Q6W5P4 1/20 0.35
THRB P10828 1/20 0.35
KDM4E B2RXH2 2/20 0.34
TP53 P04637 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5036813 0.75 KDM1A (0.46) MAPTKDM1ARCOR1RAB9AMEN1
SCHEMBL5172949 0.70 MAPT (0.38) MAPTKDM1ARCOR1RAB9AMEN1
SCHEMBL5172531 0.67 KDM1A (0.37) MAPTKDM1ARCOR1RAB9AMEN1
SCHEMBL2272537 0.64 LMNA (0.47) MAPTKDM1ARCOR1RAB9AMEN1
SCHEMBL5173896 0.63 KDM1A (0.36) MAPTKDM1ARCOR1RAB9AMEN1
SCHEMBL5495213 0.63 KDM1A (0.37) MAPTKDM1ARCOR1SMN1; SMN2THRB
SCHEMBL435115 0.60 KDM1A (0.46) MAPTKDM1ARCOR1RAB9AMEN1
SCHEMBL19610150 0.59 LMNA (0.42) MAPTKDM1ARCOR1RAB9AMEN1
SCHEMBL5172917 0.59 POLB (0.36) MAPTKDM1ARCOR1RAB9AMEN1
SCHEMBL5041555 0.59 NTRK1 (0.44) MAPTKDM1ARCOR1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276089-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-10-02 US claimed
US-20060042025-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof NOXELL CORPORATION 2006-03-02 US claimed
US-7276089-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-10-02 US disclosed
EP-1781240-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2007-05-09 EP disclosed
WO-2006026487-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2006-03-09 WO disclosed
US-20060042025-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof NOXELL CORPORATION 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060042025-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, KDM5A, KDM5C MAPT 1271/4885KDM1A 366/4885RCOR1 3357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.